Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective

Nanocarriers in The Treatment of Head and Neck Cancer

Author(s): Ashish Garg*, Vaibhav Kumar S. Gawali, Rupesh K. Gautam, Rajeev K. Singla and Sumel Ashique

Pp: 255-279 (25)

DOI: 10.2174/9789815080506123010012

* (Excluding Mailing and Handling)

Abstract

Nowadays, Head and neck cancer is treated as a major disease worldwide. Several types of treatments are involved in this type of cancer, including immunotherapy, chemotherapy, radiation therapy, and surgery. Considering the clinical results from the past decades, these types of treatments resulted in no significant improvement in survival rates. To overcome these issues, versatile nanoparticles targeting selective tumors are considered. The targeted therapeutics based on the nanoparticle has a wide range of applications, such as photothermal therapy, radiosensitization, chemotherapeutic drug delivery, and gene splicing. In this study, we have discussed the recent advancement in targeted therapeutics based on nanoparticles for head and neck cancer. Further, we have described the targets in Head and Neck cancer and, thus, shared future perspectives.


Keywords: Head and Neck Cancer, Nanocarriers, Nanoparticles, Liposomes, Targeting.

Related Journals
Related Books
© 2024 Bentham Science Publishers | Privacy Policy